German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers
Krämer A, Sommer D, Hahn EG, Riecken E-O (1986)
Klinische Wochenschrift 64(15): 688-694.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Autor*in
Krämer, AlexanderUniBi 
;
Sommer, D.;
Hahn, E. G.;
Riecken, Ernst-Otto
;
Sommer, D.;
Hahn, E. G.;
Riecken, Ernst-OttoEinrichtung
Stichworte
Hepatitis B;
Age;
Vaccination;
Immunogenicity;
Dosage
Erscheinungsjahr
1986
Zeitschriftentitel
Klinische Wochenschrift
Band
64
Ausgabe
15
Seite(n)
688-694
ISSN
0023-2173
eISSN
1432-1440
Page URI
https://pub.uni-bielefeld.de/record/1784211
Zitieren
Krämer A, Sommer D, Hahn EG, Riecken E-O. German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers. Klinische Wochenschrift. 1986;64(15):688-694.
Krämer, A., Sommer, D., Hahn, E. G., & Riecken, E. - O. (1986). German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers. Klinische Wochenschrift, 64(15), 688-694. https://doi.org/10.1007/BF01712053
Krämer, Alexander, Sommer, D., Hahn, E. G., and Riecken, Ernst-Otto. 1986. “German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers”. Klinische Wochenschrift 64 (15): 688-694.
Krämer, A., Sommer, D., Hahn, E. G., and Riecken, E. - O. (1986). German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers. Klinische Wochenschrift 64, 688-694.
Krämer, A., et al., 1986. German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers. Klinische Wochenschrift, 64(15), p 688-694.
A. Krämer, et al., “German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers”, Klinische Wochenschrift, vol. 64, 1986, pp. 688-694.
Krämer, A., Sommer, D., Hahn, E.G., Riecken, E.-O.: German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers. Klinische Wochenschrift. 64, 688-694 (1986).
Krämer, Alexander, Sommer, D., Hahn, E. G., and Riecken, Ernst-Otto. “German experimental hepatitis B vaccine: influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers”. Klinische Wochenschrift 64.15 (1986): 688-694.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
Dieses Objekt ist durch das Urheberrecht und/oder verwandte Schutzrechte geschützt. [...]
Volltext(e)
Name
Access Level
Open Access
Zuletzt Hochgeladen
2019-09-06T08:48:54Z
MD5 Prüfsumme
7bbf48cb1e25c91ea2b21d58a25a1665
Daten bereitgestellt von European Bioinformatics Institute (EBI)
9 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Primary vaccine failure to routine vaccines: Why and what to do?
Wiedermann U, Garner-Spitzer E, Wagner A., Hum Vaccin Immunother 12(1), 2016
PMID: 26836329
Wiedermann U, Garner-Spitzer E, Wagner A., Hum Vaccin Immunother 12(1), 2016
PMID: 26836329
Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cells.
Voysey M, Barker CI, Snape MD, Kelly DF, Trück J, Pollard AJ., Vaccine 34(14), 2016
PMID: 26920472
Voysey M, Barker CI, Snape MD, Kelly DF, Trück J, Pollard AJ., Vaccine 34(14), 2016
PMID: 26920472
Maternal anti-HBVs suppress the immune response of infants to hepatitis B vaccine.
Chen X, Gui X, Zhang L, Huang F, Zhong H, Pang Z, Wang S, Tang L, Fu L, Peng Y, Shellman Y., J Viral Hepat 23(12), 2016
PMID: 27469237
Chen X, Gui X, Zhang L, Huang F, Zhong H, Pang Z, Wang S, Tang L, Fu L, Peng Y, Shellman Y., J Viral Hepat 23(12), 2016
PMID: 27469237
Predictors of poor response after primary immunization of hepatitis B vaccines for infants and antibody seroprotection of booster in a metropolis of China.
Li J, Hu J, Liang X, Wang F, Li Y, Yuan ZA., Asia Pac J Public Health 27(2), 2015
PMID: 24097922
Li J, Hu J, Liang X, Wang F, Li Y, Yuan ZA., Asia Pac J Public Health 27(2), 2015
PMID: 24097922
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, Roggendorf M, Roggendorf H, Lindemann M., Vaccine 32(39), 2014
PMID: 24975813
Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, Roggendorf M, Roggendorf H, Lindemann M., Vaccine 32(39), 2014
PMID: 24975813
The statistical analysis of immunogenicity data in vaccine trials. A review of methodologies and issues.
Horne AD., Ann N Y Acad Sci 754(), 1995
PMID: 7625669
Horne AD., Ann N Y Acad Sci 754(), 1995
PMID: 7625669
Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination.
Hess G, Hingst V, Cseke J, Bock HL, Clemens R., Eur J Clin Microbiol Infect Dis 11(4), 1992
PMID: 1396753
Hess G, Hingst V, Cseke J, Bock HL, Clemens R., Eur J Clin Microbiol Infect Dis 11(4), 1992
PMID: 1396753
A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study.
Bock HL, Klockmann U, Jüngst C, Schindel-Künzel F, Theobald K, Zerban R., Vaccine 8(1), 1990
PMID: 2316281
Bock HL, Klockmann U, Jüngst C, Schindel-Künzel F, Theobald K, Zerban R., Vaccine 8(1), 1990
PMID: 2316281
Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing.
Krämer A, Herth D, von Keyserlingk HJ, Ludwig WD, Hampl H, Sommer D, Hahn EG, Riecken EO., Klin Wochenschr 66(15), 1988
PMID: 2971838
Krämer A, Herth D, von Keyserlingk HJ, Ludwig WD, Hampl H, Sommer D, Hahn EG, Riecken EO., Klin Wochenschr 66(15), 1988
PMID: 2971838
28 References
Daten bereitgestellt von Europe PubMed Central.
[Vaccination of uremic patients against hepatitis B]
Bommer J, Deinhardt F, Jilg W, Darai D, Andrassy K, Ritz E., Dtsch. Med. Wochenschr. 108(48), 1983
PMID: 6641534
Bommer J, Deinhardt F, Jilg W, Darai D, Andrassy K, Ritz E., Dtsch. Med. Wochenschr. 108(48), 1983
PMID: 6641534
J, Lancet 455(I), 1981
J, Lancet I(), 1981
Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?
Dienstag JL, Ryan DM., Am. J. Epidemiol. 115(1), 1982
PMID: 7055128
Dienstag JL, Ryan DM., Am. J. Epidemiol. 115(1), 1982
PMID: 7055128
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF., Ann. Intern. Med. 101(1), 1984
PMID: 6233921
Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF., Ann. Intern. Med. 101(1), 1984
PMID: 6233921
PR, 1982
KH, Z Gastroenterol 24(), 1986
[Results of active preventive vaccination against hepatitis B with a German vaccine]
Henning H, Laufs R, Katzner K, Bredehorst R., Z Gastroenterol 21(3), 1983
PMID: 6868717
Henning H, Laufs R, Katzner K, Bredehorst R., Z Gastroenterol 21(3), 1983
PMID: 6868717
PG, Devel biol Stand 54(), 1983
FB, 1982
[Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B]
Jilg W, Schmidt M, Zachoval R, Deinhardt F., Dtsch. Med. Wochenschr. 110(6), 1985
PMID: 3967610
Jilg W, Schmidt M, Zachoval R, Deinhardt F., Dtsch. Med. Wochenschr. 110(6), 1985
PMID: 3967610
P, Lancet I(), 1981
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
Milich DR, Chisari FV., J. Immunol. 129(1), 1982
PMID: 6177755
Milich DR, Chisari FV., J. Immunol. 129(1), 1982
PMID: 6177755
DR, J Immunol 3(), 1983
DR, J Immunol 2(), 1983
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
Milich DR, Leroux-Roels GG, Louie RE, Chisari FV., J. Exp. Med. 159(1), 1984
PMID: 6198427
Milich DR, Leroux-Roels GG, Louie RE, Chisari FV., J. Exp. Med. 159(1), 1984
PMID: 6198427
Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus (HBV) envelope gene.
Neurath AR, Kent SB, Strick N, Stark D, Sproul P., J. Med. Virol. 17(2), 1985
PMID: 4056755
Neurath AR, Kent SB, Strick N, Stark D, Sproul P., J. Med. Virol. 17(2), 1985
PMID: 4056755
EE, 1982
AUTHOR UNKNOWN, 0
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W., N. Engl. J. Med. 311(8), 1984
PMID: 6235453
Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W., N. Engl. J. Med. 311(8), 1984
PMID: 6235453
The immune response of healthy adults to a reduced dose of hepatitis B vaccine.
Szmuness W, Stevens CE, Harley EJ, Zang EA, Taylor PE, Alter HJ., J. Med. Virol. 8(2), 1981
PMID: 7299378
Szmuness W, Stevens CE, Harley EJ, Zang EA, Taylor PE, Alter HJ., J. Med. Virol. 8(2), 1981
PMID: 7299378
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A., Hepatology 1(5), 1981
PMID: 7030902
Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A., Hepatology 1(5), 1981
PMID: 7030902
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, Chen GT, Kellner A., N. Engl. J. Med. 307(24), 1982
PMID: 6755247
Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, Chen GT, Kellner A., N. Engl. J. Med. 307(24), 1982
PMID: 6755247
[Preparation and testing of a hepatitis B vaccine (author's transl)]
Thomssen R, Gerlich W, Bottcher U, Stibbe W, Legler K, Weinmann E, Klinge O, Pfeifer U., Dtsch. Med. Wochenschr. 107(4), 1982
PMID: 7056165
Thomssen R, Gerlich W, Bottcher U, Stibbe W, Legler K, Weinmann E, Klinge O, Pfeifer U., Dtsch. Med. Wochenschr. 107(4), 1982
PMID: 7056165
R, Devel Biol Stand 54(), 1983
ME, Transfusion 21(), 1981
[Active immunization against hepatitis B]
Wildgrube HJ, Classen M, von Lohr R, Kurth R, Brede HD., Dtsch. Med. Wochenschr. 109(7), 1984
PMID: 6230216
Wildgrube HJ, Classen M, von Lohr R, Kurth R, Brede HD., Dtsch. Med. Wochenschr. 109(7), 1984
PMID: 6230216
G, Dtsch Med Wochenschr 108(), 1983
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 2945040
PubMed | Europe PMC
Suchen in
Google Scholar